Myoview (Medi-Physics Inc. dba GE Healthcare)


Welcome to the PulseAid listing for the Myoview drug offered from Medi-Physics Inc. dba GE Healthcare. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Medi-Physics Inc. dba GE Healthcare
NON-PROPRIETARY NAME: Tetrofosmin
SUBSTANCE NAME: TETROFOSMIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-02-26
END MARKETING DATE: 0000-00-00


Myoview HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMyoview from Medi-Physics Inc. dba GE Healthcare
LABELER NAME: Medi-Physics Inc. dba GE Healthcare
DEA SCHEDULE:
ACTIVE STRENGTH: 1.38(mg/1)
START MARKETING DATE: 2009-02-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17156-026_aaa8939a-e4f3-4b07-b54b-bd2a86c5c944
PRODUCT NDC: 17156-026
APPLICATION NUMBER: NDA020372

Other TETROFOSMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationTetrofosmin
Medi-Physics Inc. dba GE HealthcareMyoview